IPSEN PHARMA

In News

Ipsen announces the availability of its 2025 Universal Registration Document - au.finance.yahoo.com

au.finance.yahoo.com - Apr 01, 2026

Ipsen to withdraw cancer drug acquired in buyout due to safety concerns - BioPharma Dive

BioPharma Dive - Mar 09, 2026

Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial - Fierce Pharma

Fierce Pharma - Mar 09, 2026

Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail - fiercebiotech.com

fiercebiotech.com - Dec 19, 2025

Ipsen appoints Michelle Werner as Executive Vice President, President of North America - PMLiVE

PMLiVE - Mar 30, 2026

Fired Ipsen Director Accuses The Pharmaceutical Co. Of Bias - Law360

Law360 - Mar 24, 2026

Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR - GlobeNewswire

GlobeNewswire - Mar 18, 2026

Ipsen announces new data on Dysport in neurological disease - PharmaTimes

PharmaTimes - Jan 15, 2026

Ipsen announced overall Pharma Industry Company of the Year in 2021 Pharma Industry Awards - UK Ireland - Ipsen

Ipsen - Nov 28, 2025

Ipsen outlays $1bn for China-based Simcere’s preclinical ADC - Pharmaceutical Technology

Pharmaceutical Technology - Dec 23, 2025

Ipsen continues ADC push with $1B deal for Simcere's preclinical LRRC15-targeting asset - fiercebiotech.com

fiercebiotech.com - Dec 22, 2025

Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance - Yahoo Finance

Yahoo Finance - Feb 11, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment